Hairy Cell Leukemia - 25 Studies Found

Completed : Immunotoxin Therapy in Treating Patients With Hairy Cell Leukemia
: Leukemia
: 2001-08-10
: Biological: BL22 immunotoxin
Recruiting : Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
:
  • Hairy Cell Leukemia (HCL)
  • Chronic Lymphocytic Leukemia (CLL) : 2010-03-13
Completed : Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery
:
  • Adult Acute Lymphoblastic Leukemia in Remission
  • Adult B Acute Lymphoblastic Leukemia
    • : 2008-01-30
    :
    • Drug: Dasatinib Given PO
Active, not recruiting : Bortezomib and Filgrastim in Promoting Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma Undergoing Stem Cell Transplant
:
  • Adult Grade III Lymphomatoid Granulomatosis
  • B-cell Chronic Lymphocytic Leukemia
  • : 2014-01-14
    :
    • Drug: bortezomib Given IV
COMPLETED : BRAF Inhibitor, Vemurafenib, in Patients With Relapsed or Refractory Hairy Cell Leukemia
: Hairy Cell Leukemia
: 2024-11-21
: Patients will receive vemurafenib at a dose of 960mg orally b.i.d.continuously in cycles of 4 weeks (28 days) as outpatient.A bone marrow
<<< Previous